| __timestamp | Amicus Therapeutics, Inc. | Viking Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 20717000 | 1244910 |
| Thursday, January 1, 2015 | 47269000 | 5029636 |
| Friday, January 1, 2016 | 71151000 | 4846776 |
| Sunday, January 1, 2017 | 88671000 | 5329003 |
| Monday, January 1, 2018 | 127200000 | 7121000 |
| Tuesday, January 1, 2019 | 169861000 | 9128000 |
| Wednesday, January 1, 2020 | 156407000 | 10731000 |
| Friday, January 1, 2021 | 192710000 | 10701000 |
| Saturday, January 1, 2022 | 213041000 | 16121000 |
| Sunday, January 1, 2023 | 275270000 | 37021000 |
Cracking the code
In the competitive world of biotechnology, managing Selling, General, and Administrative (SG&A) expenses is crucial for financial health. From 2014 to 2023, Amicus Therapeutics, Inc. consistently reported higher SG&A expenses compared to Viking Therapeutics, Inc. In 2023, Amicus's SG&A costs surged to nearly 275 million, marking a 1,230% increase from 2014. Meanwhile, Viking's expenses grew to approximately 37 million, a 2,870% rise over the same period. This stark contrast highlights Amicus's larger operational scale, while Viking's leaner approach may appeal to investors seeking efficiency. The data suggests that while Amicus invests heavily in its operations, Viking maintains a more conservative expenditure strategy. As the biotech industry evolves, these financial strategies will play a pivotal role in shaping each company's future.
SG&A Efficiency Analysis: Comparing Eli Lilly and Company and Viking Therapeutics, Inc.
SG&A Efficiency Analysis: Comparing Vertex Pharmaceuticals Incorporated and Amicus Therapeutics, Inc.
Alnylam Pharmaceuticals, Inc. or Viking Therapeutics, Inc.: Who Manages SG&A Costs Better?
SG&A Efficiency Analysis: Comparing Teva Pharmaceutical Industries Limited and Amicus Therapeutics, Inc.
Biogen Inc. and Viking Therapeutics, Inc.: SG&A Spending Patterns Compared
Comparing SG&A Expenses: Viatris Inc. vs Amicus Therapeutics, Inc. Trends and Insights
Insmed Incorporated or Amicus Therapeutics, Inc.: Who Manages SG&A Costs Better?
Selling, General, and Administrative Costs: Ascendis Pharma A/S vs Amicus Therapeutics, Inc.
Comparing SG&A Expenses: Halozyme Therapeutics, Inc. vs Viking Therapeutics, Inc. Trends and Insights
Cytokinetics, Incorporated or Viking Therapeutics, Inc.: Who Manages SG&A Costs Better?
Ionis Pharmaceuticals, Inc. and Amicus Therapeutics, Inc.: SG&A Spending Patterns Compared
Who Optimizes SG&A Costs Better? Viking Therapeutics, Inc. or Agios Pharmaceuticals, Inc.